Gossamer Bio Inc
GOSS
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.44M
Close$
$9.53
11% downside
Current Fair Value
11% downsideOvervalued by 11% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.44 Million |
|---|---|
| Enterprise Value | $63.40 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-59.64 |
| Beta | 2 |
| Outstanding Shares | 2,759,616 |
Return
| Return on Equity | 133.17% |
|---|---|
| Return on Assets | -162.91% |
| Return on Invested Capital | 347.21% |
Valuation & Multiples
| P/E Ratio | -0.24 |
|---|---|
| PEG | 0.16 |
| Price to Sales | 0.56 |
| Price to Book Ratio | -0.31 |
| Enterprise Value to Revenue | 1.19 |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.62 |
| Debt to Equity | -0.42 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-9.87
Average shareholder expectationRevenue Estimate
$3.63 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-3.93
Average shareholder expectationRevenue Estimate
$10.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0746▼ 10.73% |
|---|---|
| Total Calls | 1,474,800▼ 48.13% |
| Total Puts | 110,000▼ 78.74% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 158.71%▲ 86.19% |
|---|---|
| Total Invested | $61.00M▲ 8.32% |
| Investors Holding | 176▼ 23.00% |
ESG Score
No data
About Gossamer Bio Inc
CEO: Sheila Gujrathi